Regulation of p53 Expression in Response to 5-Fluorouracil in Human Cancer RKO Cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Cancer Research

• Publication date

  2007-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-2890PMID 17634554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Negative feedback regulation of wild-type p53 biosynthesis

  2007cited by this paper
• Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer

  2006cited by this paper
• Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.

  2006cited by this paper
• Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells*

  2004cited by this paper
• Regulation of p 53 Stability and Function in HCT 116 Colon Cancer Cells Running title : p 53 regulation in colon cancer cells

  2003cited by this paper
• p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

  2000cited by this paper
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

  2000cited by this paper
• Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex

  1999cited by this paper
• Regulation of p53 expression by thymidylate synthase.

  1999cited by this paper
• p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage

  1999cited by this paper
• p53 in tumor progression: life, death, and everything.

  1998cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998cited by this paper
• An insight into the life of p53: a protein coping with many functions! Review of the 9th p53 Workshop, Crete, May 9-13, 1998.

  1998cited by this paper
• DNA damage induces phosphorylation of the amino terminus of p53.

  1997cited by this paper
• Synergistic activation of transcription by CBP and p53

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Participation of the human p53 3′UTR in translational repression and activation following γ‐irradiation

  1997cited by this paper
• Cytoplasmic p53 polypeptide is associated with ribosomes

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Translational regulation of human p53 gene expression.

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.

  1996cited by this paper
• Negative feedback regulation of wild‐type p53 biosynthesis.

  1995cited by this paper
• Induction of the growth inhibitor IGF-binding protein 3 by p53

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1994cited by this paper
• Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

  1993cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

  1993cited by this paper
• Induction of cellular p53 activity by DNA-damaging agents and growth arrest

  1993cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• THE P53 TUMOR SUPPRESSOR GENE

  1991cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells

  1984cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer

  2025cites this paper
• Water-based propolis enhances 5-fluorouracil drug efficiency in gastric and colorectal cancer cells through cell stress response, anti-migratory, and apoptotic effects regardless of p53 status

  2025cites this paper
• A TP53 Intron-Derived Peptide Promotes Tumor Survival

  2025cites this paper
• p53-inducible lncRNA LOC644656 causes genotoxic stress-induced stem cell maldifferentiation and cancer chemoresistance

  2025cites this paper
• Novel siRNA Delivery System Targeting β-Catenin in Colorectal Cancer Cells: Synergistic effect with 5-Fluorouracil

  2025cites this paper
• Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development

  2023cites this paper
• 5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity

  2023cites this paper
• Exploring the Antioxidant Potential of Tragia volubilis L.: Mitigating Chemotherapeutic Effects of Doxorubicin on Tumor Cells

  2023cites this paper
• An updated review on properties, nanodelivery systems, and analytical methods for the determination of 5-fluorouracil in pharmaceutical and biological samples.

  2022cites this paper
• Coiled-coil domain containing 3 suppresses breast cancer growth by protecting p53 from proteasome-mediated degradation

  2022cites this paper
• Cross-Talk between p53 and Wnt Signaling in Cancer

  2022cites this paper
• Photobiomodulation Therapy Minimizes the DNA Damage in 5FU‐Treated Gingival Fibroblasts

  2022cites this paper
• Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine

  2022cites this paper
• SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.

  2020cites this paper
• 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

  2020cites this paper
• Topical Therapy for the Treatment of Basal Cell Carcinoma

  2019cites this paper
• Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation

  2019cites this paper
• Targeting autophagy in gastrointestinal malignancy by using nanomaterials as drug delivery systems.

  2018cites this paper
• Identification of Differential Expression of p53 associated RNAs at 3 Different Treatment Timepoints, and Association with ChIP-seq Identified p53 Genes.

  2017influential citation
• Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response

  2017cites this paper
• MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

  2017cites this paper
• p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA

  2016influential citation
• Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges

  2016cites this paper
• Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo.

  2016cites this paper
• In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2/4–p53 interaction

  2015cites this paper
• Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells

  2014cites this paper
• A Compensatory Role of NF-κB to p53 in Response to 5-FU–Based Chemotherapy for Gastric Cancer Cell Lines

  2014cites this paper
• Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype

  2013cites this paper
• p53 Cooperates with Sp1 to Regulate Breed-Dependent Expression of Glucocorticoid Receptor in the Liver of Preweaning Piglets

  2013cites this paper
• The involvement of WT1 in the regulation of GADD45a in response to genotoxic stress.

  2013cites this paper
• Post-translational regulation enables robust p53 regulation

  2013cites this paper
• A novel DNA intercalator, 8‐methoxy pyrimido[4′,5′:4,5]thieno (2,3‐b)quinoline‐4(3H)‐one induces apoptosis in cancer cells, inhibits the tumor progression and enhances lifespan in mice with tumor

  2013cites this paper
• Mechanisms of action of topical 5-fluorouracil: Review and implications for the treatment of dermatological disorders

  2012cites this paper
• The Molecular Mechanisms of 5-Fluorouracil-Induced Apoptosis in Human Colorectal Cancer Cells and the Use of 5-FU as a Sensitising Agent to TRAIL

  2012cites this paper
• Chloroquine enhances the chemotherapeutic activity of 5‐fluorouracil in a colon cancer cell line via cell cycle alteration

  2012cites this paper
• Effects of pesticide compounds (chlorothalonil and mancozeb) and benzo[a]pyrene mixture on aryl hydrocarbon receptor, p53 and ubiquitin gene expression levels in haemocytes of soft-shell clams (Mya arenaria)

  2011cites this paper
• The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells

  2011cites this paper
• Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth

  2011cites this paper
• Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model.

  2010cites this paper
• The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound

  2010cites this paper
• Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.

  2010cites this paper
• Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues

  2010cites this paper
• Reduced ATR or Chk 1 Expression Leads to Chromosome Instability and Chemosensitization of Mismatch Repair – deficient Colorectal Cancer Cells

  2009influential citation
• P53 transcriptional activities: a general overview and some thoughts.

  2009cites this paper
• Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation*

  2009cites this paper
• Stochastic Modeling and Simulation of the p53-MDM2/MDMX Loop

  2009cites this paper
• Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.

  2009cites this paper
• Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

  2008cites this paper
• Hexachlorophene suppresses β-catenin expression by up-regulation of Siah-1 in EBV-infected B lymphoma cells

  2008cites this paper